Case ID: f-appx_496/html/0087-02.html
Source: Caselaw Access Project
Author: {"author": "PER CURIAM.", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

MERCK SHARP & DOHME CORP., MSD International GMBH, Plaintiffs-Appellees, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellant.
    No. 2012-1434.
    United States Court of Appeals, Federal Circuit.
    Feb. 7, 2013.
    
      David T. Pritikin, Sidley Austin, LLP, of Chicago, IL, argued for plaintiffs-appel-lees. With him on the brief were William H. Baumgartner, Jr. and Constantine L. Trela, Jr.; and Peter S. Choi, of Washington, DC; and Todd L. Krause, of New York, NY. Of counsel on the brief were Paul D. Matukaitis, Edward W. Murray and Lisa A. Jakob, Merck & Co., Inc., of Rahway, NJ. Of counsel was Donald A. Robinson, Robinson, Wettre & Miller LLC, of Newark, NJ.
    Thomas J. Parker, Alston & Bird, LLP, of New York, NY, argued for defendant-appellant. Of counsel were Blas P. Arroyo and Jitendra Malik, of Charlotte, NC; and Deepro Mukerjee, of New York, NY.
    DYK, MAYER, and REYNA, Circuit Judges.
   JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is

ORDERED and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.